Patterns of Pharmaceutical Industry Marketing to Physicians for Direct-Acting Antivirals, 2013 Through 2019.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Works matching IS 10600280 AND DT 2022 AND VI 56 AND IP 2
Results: 17
1
2
Semaglutide for Weight Loss.
- Published in:
- 2022
- By:
- Publication type:
- Letter
3
Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease.
- Published in:
- 2022
- By:
- Publication type:
- Letter
4
Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 155, doi. 10.1177/10600280211023492
- By:
- Publication type:
- Article
5
Impact of Prior-to-Admission Methicillin-Resistant Staphylococcus aureus Nares Screening in Critically Ill Adults With Pneumonia.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 124, doi. 10.1177/10600280211023209
- By:
- Publication type:
- Article
6
Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor–Induced Bullous Pemphigoid.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 205, doi. 10.1177/10600280211022722
- By:
- Publication type:
- Article
7
Amantadine and Fatal Events in Patients With Chronic Kidney Disease: Analysis of the Japanese Adverse Event Report Database.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
8
Impact of Interferons and Biological Drug Inhibitors of IL-2 and IL-6 on Small-Molecule Drug Metabolism Through the Cytochrome P450 System.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 170, doi. 10.1177/10600280211022281
- By:
- Publication type:
- Article
9
Beyond the Guidelines: Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 181, doi. 10.1177/10600280211022065
- By:
- Publication type:
- Article
10
Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 117, doi. 10.1177/10600280211021925
- By:
- Publication type:
- Article
11
Pharmacist-Managed Helicobacter pylori Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World Experiences.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 162, doi. 10.1177/10600280211021501
- By:
- Publication type:
- Article
12
Dosing Considerations for Combination Antistaphylococcal β-Lactam and Glyco/lipopeptide Salvage Therapy for Resistant Gram-Positive Infections: A Systematic Review.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 193, doi. 10.1177/10600280211021421
- By:
- Publication type:
- Article
13
New Drug Formulary Management and Utilization: Evidence in Sex, Race, and Ethnicity: 2019-2020.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 139, doi. 10.1177/10600280211019765
- By:
- Publication type:
- Article
14
Evaluation of Serum Sodium Correction Rates for Management of Hyponatremia in Hospitalized Patients.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 131, doi. 10.1177/10600280211019752
- By:
- Publication type:
- Article
15
Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 151, doi. 10.1177/10600280211018516
- By:
- Publication type:
- Article
16
An Evaluation of the Effect of Catheter-Directed Continuous Infusion of Local Anesthetic by Elastomeric Pump on Opioid Usage Following Donor Kidney Nephrectomy.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 146, doi. 10.1177/10600280211017894
- By:
- Publication type:
- Article
17
Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 213, doi. 10.1177/10600280211008492
- By:
- Publication type:
- Article